Hematology-Oncology Clinics of North America

Article	Citations
Screening for Colorectal Cancer	60
Epidemiology of Melanoma	58
Biology of Melanoma	52
Diagnosis and Staging of Bladder Cancer	46
Factor XI Deficiency	46
Lip and Oral Cavity Squamous Cell Carcinoma	30
The Epidemiology of Bladder Cancer	30
Colorectal Cancer in Younger Adults	26
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus	25
Von Willebrand Disease	24
Hereditary Colorectal Cancer	23
Overview of Myeloproliferative Neoplasms	23
Disorders of Fibrinogen and Fibrinolysis	21
Gene Therapy for Hemoglobinopathies	18
The Epidemiology of Central Nervous System Tumors	17
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	17
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms	17
Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)	16
Acquired Hemophilia A	15
Structural Racism and Impact on Sickle Cell Disease	15
Genetics of Myeloproliferative Neoplasms	15
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	15
Pancreatic Adenocarcinoma	15
The Role of Megakaryocytes in Myelofibrosis	15
The Microenvironment in Myeloproliferative Neoplasms	14

Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia	14
Acquired von Willebrand Syndrome	13
Immunotherapy for Head and Neck Cancer	13
Primary Central Nervous System Lymphomas	13
Developing Precision Medicine for Bladder Cancer	13
Impact of Diet and Exercise on Colorectal Cancer	12
Systemic Amyloidosis Due to Clonal Plasma Cell Diseases	11
Gene Therapy and Gene Editing for β-Thalassemia	11
Go the Distance	11
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors	11
Cancer of the Paranasal Sinuses	11
Current Clinical Investigations in Myelofibrosis	11
Central Nervous System Metastases	10
Cellular Therapy and Cytokine Treatments for Melanoma	10
Preclinical Models for Bladder Cancer Research	10
A Curative DNA Code for Hematopoietic Defects	10
Factor XIII Deficiency	10
Managing Recurrent Metastatic Head and Neck Cancer	9
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?	9
Systemic Amyloidosis due to Low-Grade Lymphoma	9
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer	9
Evolution of Gene Therapy, Historical Perspective	9
Cancer of the Larynx and Hypopharynx	9
Renal Cell Carcinoma of Variant Histology	9
Update on Radiation Therapy for Central Nervous System Tumors	9
The Process of Amyloid Formation due to Monoclonal Immunoglobulins	9
Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis	9
Hemophilia B (Factor IX Deficiency)	8
The Clinical Phenotypes of Alpha Thalassemia	8
Quality of Life in Myeloproliferative Neoplasms	8
Hemophilia A (Factor VIII Deficiency)	8
Monoclonal Antibody Therapies in Systemic Light-Chain Amyloidosis	8
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms	8
Adult Evans' Syndrome	8
Management of Rectal Cancer	8
Biology and Treatment of HER2-Low Breast Cancer	8
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	8
Quality of Life in Sickle Cell Disease	8
Salivary Gland Cancers	8
Neurofibromatoses	8
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia	7
Real World Outcomes of Patients with Bladder Cancer	7
Robotic and Endoscopic Approaches to Head and Neck Surgery	7
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	7
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer	7
Molecular Basis and Genetic Modifiers of Thalassemia	7
Fetal Hemoglobin Regulation in Beta-Thalassemia	7
Breast Cancer and Lifestyle Factors	7
Chimeric Antigen Receptor T-cell Therapy	6
Liver and Gastrointestinal Involvement	6

Immune Therapy for Chronic Lymphocytic Leukemia	6
Immunotherapy-associated Autoimmune Hemolytic Anemia	6
Molecular Biology of Bladder Cancer	6
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology	6
Imaging Advances for Central Nervous System Tumors	6
Gene Therapy for Inborn Errors of Immunity	6
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	6
Application of Stem Cell Therapy in Myelofibrosis	6
Combinatorial Approaches to the Treatment of Advanced Melanoma	6
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	6
Hematopoietic Stem Cell Transplantation in Thalassemia	6
Current Therapy for Metastatic Urothelial Carcinoma	5
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	5
Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia	5
Lung Cancer Supportive Care and Symptom Management	5
Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers	5
Liver and Gastrointestinal Involvement	5
Genetics of Pancreatic Neuroendocrine Tumors	5
Accelerated and Blast Phase Myeloproliferative Neoplasms	5
Is There a Role for Immunotherapy in Central Nervous System Cancers?	5
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia	5
State of Melanoma	5
Nonoperative Management for Rectal Cancer	5
Cancer of the Oropharynx and the Association with Human Papillomavirus	5
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art	5
Advanced Melanoma	5
Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	5
Disparities and Inequities Among Patients with Central Nervous System Tumor	5
Hereditary Renal Cell Carcinoma Syndromes	5
Epigenetic Dysregulation of Myeloproliferative Neoplasms	4
Emerging Targeted Therapy for Bladder Cancer	4
Evidence-Based Guidance for Breast Cancer Survivorship	4
Chronic Pain	4
Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	4
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	4
Central Nervous System Complications Among Oncology Patients	4
Role of Ovarian Suppression in Early Premenopausal Breast Cancer	4
Clinical Challenges with Iron Chelation in Beta Thalassemia	4
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer	4
Red Cell Antigens and Antibodies	4
Emerging Therapies in β-Thalassemia	4
Pathogenic Mechanisms in Thalassemia I	4
Surgery for Bladder and Upper Tract Urothelial Cancer	4
Supportive Care for Patients with Systemic Light Chain Amyloidosis	4
Immune Checkpoint Therapies for Melanoma	4
DAT-Negative Autoimmune Hemolytic Anemia	4
Biology and Treatment of Meningiomas	4
Surgical Management of the Axilla for Breast Cancer	4
Extracutaneous Melanoma	4
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer	4
The Gut Microbiome in Colorectal Cancer	4
Disparities in Breast Cancer Outcomes and How to Resolve Them	4
The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes	4
Genetic Modifiers of Sickle Cell Disease	4
Systemic Amyloidosis due to Monoclonal Immunoglobulins	4
The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia	4
Future Perspectives	4
Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy	3
First-Line Therapy for Chronic Lymphocytic Leukemia	3
Radiotherapy for Pancreatic Adenocarcinoma	3
Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma	3
Complications of Autoimmune Hemolytic Anemia	3
Measurable Residual Disease and Decision-Making in Multiple Myeloma	3
State of Cancer Control in South America	3
Nonsurgical Therapy for Early-Stage Lung Cancer	3
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells	3
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology	3
Management of Brain Metastases in Metastatic Renal Cell Carcinoma	3
Lung Cancer and Lifestyle Factors	3
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	3
Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms	3
Pathogenic Mechanisms in Thalassemia II	3
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer	3
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?	3
Adjuvant Therapy of Melanoma	3
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care	3
Genes as Medicine	3
Local Therapies in Advanced Colorectal Cancer	3
Updates in the Management of Warm Autoimmune Hemolytic Anemia	3
Solid Organ Transplantation	3

The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies	3
The Cardiopulmonary Complications of Sickle Cell Disease	3
Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma	2
Unmet Need in Essential Thrombocythemia and Polycythemia Vera	2
Thalassemia	2
Management of Newly Diagnosed Multiple Myeloma Today, and in the Future	2
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	2
Molecular Pathogenesis of Multiple Myeloma	2
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia	2
Immune-Pathogenesis of Myeloma	2
An Overview of Cervical Cancer Prevention and Control in Latin America and the Caribbean Countries	2
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer	2
Adeno-Associated Virus Vector Design–Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle	2
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	2
Novel Agents in Waldenström Macroglobulinemia	2
Allogeneic Transplant and Gene Therapy	2
New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia: Traditional and Novel Tests	2
Genomics of Resistance to Targeted Therapies	2
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?	2
The Impact of AL Amyloidosis	2
Genotyping and the Future of Transfusion in Sickle Cell Disease	2
Inherited Platelet Disorders	2
Peripheral Nervous System Involvement	2
Breast Cancer Pathology in the Era of Genomics	2
Advancing Effective Clinical Trial Designs for Myelofibrosis	2
Immunotherapy for Colorectal Cancer	2
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia	2
Colorectal Cancer: Advancing Science, Improving Access, and Refining Therapy	2
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	2
Multidisciplinary Management of Brain Metastasis from Breast Cancer	2
Radiologic Evaluation of the Head and Neck Cancer Patient	2
Advances in Surgery and (Neo) Adjuvant Therapy in the Management of Pancreatic Cancer	2
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	2
First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma	2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer	2
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease	2
Current Perioperative Therapy for Muscle Invasive Bladder Cancer	2
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma	2
Central Nervous System Tumor Classification	2
Management of Peritoneal Disease in Colorectal Cancer	2
Prognostic and Predictive Implications of Cytogenetics and Genomics	2
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma	2
More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries	1
Targeted Therapy for Non–Small Cell Lung Cancer	1
Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy	1
Clinical Vignettes, Part II: Eyes, Teeth, and Bone	1
Prognostic Models in Metastatic Renal Cell Carcinoma	1
Novel Immune Therapies for Renal Cell Carcinoma	1
Clinical Complications and Their Management	1
Evaluation and Management of Bing–Neel Syndrome	1
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	1
Inequity in Cancer and Cancer Care Delivery in the United States	1
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	1
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia	1
Introduction to the Thalassemia Syndromes	1
Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia	1
Breast Cancer in India	1
Traipsing Through Muddy Waters	1
Sickle Cell Disease and the Kidney	1
Toxicity Management of Systemic Kidney Cancer Therapies	1
Surgical Management of Localized Disease and Small Renal Masses	1
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	1
Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma	1
Approach to the Patient with Bleeding	1
Managing First-Line Metastatic Renal Cell Carcinoma	1
Smoldering Multiple Myeloma	1
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia	1
State of the Art of Pathologic and Molecular Testing	1
Approach to High-Risk Multiple Myeloma	1
Novel Targeted Therapies for Renal Cell Carcinoma	1
Early Detection of Precursor Diseases of Multiple Myeloma	1
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	1
Role of Surgery in Metastatic Renal Cell Carcinoma	1
Investigation and Management of Immunoglobulin M– and Waldenström-Associated Peripheral Neuropathies	1
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	1
Chimeric Antigen Receptor T Cells in Multiple Myeloma	1
Hemophilia A/B	1
New Insights into Adjuvant Therapy for Localized Colon Cancer	1
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	1
Breast Cancer Disparities and Innovations	1
New Therapies on the Horizon	1
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors	1
Cutaneous Malignancies of the Head and Neck	1
Renal Cell Cancer	1
Locally Advanced Lung Cancer	1
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies	1
Advances in Surgical Techniques for Lung Cancer	1
Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis	1
Leptomeningeal Disease	1
Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders	1
Disparities in Cancer Control in Central America and the Caribbean	1
What Is New in Small Cell Lung Cancer	1